Furst D E
University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick.
J Rheumatol Suppl. 1992 Apr;33:11-5.
Using patient related examples, the toxicity of nonsteroidal antiinflammatory drugs and disease modifying antirheumatic drugs (DMARD) in juvenile arthritis (JA) is discussed. DMARD combinations are also reviewed. Gastrointestinal side effects are not emphasized. Rather, central nervous system, hepatic, and renal effects are discussed. Ibuprofen is safer than aspirin and has a generally good record. Although data is not excellent and often relies on open studies, hydroxychloroquine is probably the safest DMARD. Methotrexate appears safe, but studies in adults mandate some continued caution in its use in children. Combination DMARD therapy, while used, is dependent on largely open or anecdotal data in adults. The efficacy and toxicity of DMARD combinations are not well understood.
通过患者相关实例,讨论了非甾体抗炎药和改善病情抗风湿药(DMARD)在青少年关节炎(JA)中的毒性。还对DMARD联合用药进行了综述。未强调胃肠道副作用。而是讨论了中枢神经系统、肝脏和肾脏方面的影响。布洛芬比阿司匹林更安全,总体记录良好。尽管数据并不完善且常依赖开放性研究,但羟氯喹可能是最安全的DMARD。甲氨蝶呤似乎是安全的,但成人研究表明在儿童中使用仍需持续谨慎。DMARD联合治疗虽然有应用,但很大程度上依赖于成人的开放性或轶事性数据。DMARD联合用药的疗效和毒性尚未得到充分了解。